Date | Time | Source | Headline | Symbol | Company |
05/17/2024 | 5:18PM | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
05/14/2024 | 8:00AM | Business Wire | U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute | NYSE:IQV | IQVIA Holdings Inc |
05/10/2024 | 4:35PM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:IQV | IQVIA Holdings Inc |
05/09/2024 | 5:09PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
05/09/2024 | 5:08PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
05/09/2024 | 5:06PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
05/09/2024 | 5:06PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
05/09/2024 | 5:05PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
05/09/2024 | 4:15PM | Business Wire | IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024 | NYSE:IQV | IQVIA Holdings Inc |
05/02/2024 | 7:00AM | Business Wire | IQVIA Reports First-Quarter 2024 Results | NYSE:IQV | IQVIA Holdings Inc |
04/15/2024 | 4:15PM | Business Wire | IQVIA to Announce First-Quarter 2024 Results on May 2, 2024 | NYSE:IQV | IQVIA Holdings Inc |
04/08/2024 | 4:01PM | Business Wire | IQVIA and Salesforce Expand Global Partnership to Accelerate the Development of Life Sciences Cloud | NYSE:IQV | IQVIA Holdings Inc |
03/06/2024 | 4:15PM | Business Wire | IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024 | NYSE:IQV | IQVIA Holdings Inc |
03/01/2024 | 7:49PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:IQV | IQVIA Holdings Inc |
02/26/2024 | 8:00AM | Business Wire | IQVIA Publishes its 2023 Environmental, Social and Governance Report | NYSE:IQV | IQVIA Holdings Inc |
02/23/2024 | 4:17PM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NYSE:IQV | IQVIA Holdings Inc |
02/23/2024 | 9:00AM | Business Wire | Global Biopharma R&D Boasts Increased Funding, Productivity and Product Launches in 2023, says IQVIA Institute Report | NYSE:IQV | IQVIA Holdings Inc |
02/21/2024 | 5:08PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
02/21/2024 | 4:15PM | Business Wire | IQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech and Life Sciences Access Day on February 29, 2024 | NYSE:IQV | IQVIA Holdings Inc |
02/16/2024 | 5:20PM | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:IQV | IQVIA Holdings Inc |
02/14/2024 | 7:05AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:IQV | IQVIA Holdings Inc |
02/14/2024 | 7:00AM | Business Wire | IQVIA Reports Fourth-Quarter and Full-Year 2023 Results; Issues Full-Year 2024 Guidance | NYSE:IQV | IQVIA Holdings Inc |
02/13/2024 | 5:11PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
02/13/2024 | 5:08PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
02/08/2024 | 5:20PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
02/08/2024 | 5:18PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
02/08/2024 | 5:17PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
02/08/2024 | 5:15PM | Edgar (US Regulatory) | Form 5 - Annual statement of changes in beneficial ownership of securities | NYSE:IQV | IQVIA Holdings Inc |
02/06/2024 | 9:00AM | Business Wire | IQVIA Named to Fortune® World's Most Admired Companies™ List, Ranked #1 in Its Sector for the Third Consecutive Year | NYSE:IQV | IQVIA Holdings Inc |
01/24/2024 | 4:15PM | Business Wire | IQVIA to Announce Fourth-Quarter and Full-Year 2023 Results on February 14, 2024 | NYSE:IQV | IQVIA Holdings Inc |